Center for Health Care Evaluation, VA Palo Alto Health Care System and Stanford University School of Medicine, Menlo Park, CA 94025, USA.
J Subst Abuse Treat. 2012 Jan;42(1):102-7. doi: 10.1016/j.jsat.2011.07.005. Epub 2011 Aug 11.
Availability and consideration of pharmacotherapy for the treatment of alcohol use disorders (AUD) are now consensus standards for evidence-based treatment. This study compares three competing specifications of the proportion of patients with AUD receiving approved medications. We examined how altering the numerator and denominator definitions affects observed rates of pharmacotherapy use and facilities' percentile ranks. Using pharmacy and administrative data from the Veterans Health Administration (VHA), three measures of pharmacotherapy receipt were calculated for 129 VHA facilities. Difference in measure specifications alters the overall estimates of pharmacotherapy receipt but unevenly across facilities, with some experiencing no change in percentile rank and others decreasing or increasing by over a quartile. The results demonstrate that the quality measures are not interchangeable, and the choice of which version to implement is of high consequence for some facilities.
目前,酒精使用障碍(AUD)治疗的药物治疗的可及性和考虑已成为循证治疗的共识标准。本研究比较了 AUD 患者接受批准药物治疗的三种竞争规范。我们研究了改变分子和分母定义如何影响观察到的药物治疗使用率和设施的百分位排名。使用退伍军人健康管理局(VHA)的药房和行政数据,为 129 个 VHA 设施计算了三种药物治疗接受率的措施。衡量标准的差异改变了药物治疗接受率的总体估计,但在各个设施之间并不均衡,有些设施的百分位排名没有变化,而有些设施的百分位排名则下降或上升超过四分之一。结果表明,质量指标不能互换,对于某些设施来说,选择实施哪个版本具有重要意义。